Patent: 6,410,238
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 6,410,238
Title: | Box-dependent Myc-interacting protein (Bin1) compositions and uses thereof |
Abstract: | The present invention provides Bin1 genomic sequences and proteins encoded thereby. Also provided are compositions and methods utilizing these sequences and proteins in the diagnosis and treatment of cancers and hyperplastic disease states. Further provided are oligonucleotides derived from sequences encoding Bin1, as well as compositions and methods utilizing same for diagnostic and therapeutic purposes. |
Inventor(s): | Prendergast; George C. (Bala Cynwyd, PA), Sakamuro; Daitoku (West Lafayette, IN) |
Assignee: | The Wistar Institute of Anatomy and Biology (Philadelphia, PA) |
Application Number: | 09/445,247 |
Patent Claims: | see list of patent claims |
Details for Patent 6,410,238
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2017-06-06 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2017-06-06 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2017-06-06 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |